naproxen-n-butyl nitrate: Clinical Trials

10 trials of naproxen-n-butyl nitrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated. 6 Phase 1, 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 33Completed 3
Phase 21Terminated 1

Follow naproxen-n-butyl nitrate: new trials by email Literature Review of naproxen-n-butyl nitrate trials Research Report on naproxen-n-butyl nitrate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
naproxcinod 750 bid, naproxcinod 3000 mg od, naproxen 500 mg bid - Pharmacokinetics
Phase 1CompletedNicOx242010-01-012011-08-11
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide
naproxcinod, Naproxen, placebo - Renal Hemodynamics
Phase 1CompletedNicOx312009-01-012011-06-17
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
naproxcinod - Renal Failure
Phase 1CompletedNicOx322008-05-012009-01-28
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
naproxcinod 375 mg -750 mg -1125 mg bid, naproxen 250 mg - 500mg -750 mg bid - Osteoarthritis, Hypertension
Phase 1CompletedNicOx1202008-03-012011-06-17
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
naproxcinod 375 mg bid, naproxcinod 750 mg bid, naproxen 250 mg bid - Osteoarthritis, Hypertension
Phase 1CompletedNicOx3002008-03-012011-06-17
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
naproxcinod - Liver Disease
Phase 1CompletedNicOx242008-01-012011-06-17
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Naproxcinod, Naproxen, Placebo - Osteoarthritis, Osteoarthritis, Hip
Phase 3CompletedNicOx8002007-06-012009-02-20
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Naproxcinod 375 mg bid, Naproxcinod 750 mg bid, Naproxen 500 mg bid - Osteoarthritis
Phase 3CompletedNicOx10202007-04-012011-06-17
Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Placebo, Naproxcinod 375 mg, Naproxen - Osteoarthritis
Phase 3CompletedNicOx9182005-12-012011-06-17
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Calcitriol, Naproxen-n-butyl nitrate - Prostatic Neoplasms, Prostate Cancer
Phase 2TerminatedStanford University202005-03-012013-01-28

Conditions studied

Osteoarthritis (5)  ·  Hypertension (2)  ·  Arthritis (1)  ·  Liver Diseases (1)  ·  Osteoarthritis, Hip (1)  ·  Prostatic Neoplasms (1)  ·  Renal Insufficiency (1)

Sponsors

NicOx (9)  ·  Stanford University (1)

Countries

United States (7)  ·  Canada (1)

Top investigators

Antonio Rusca, MD FMH (1)  ·  Dr. Sandy Srinivas (1)

Results publications

PMID 20202489, PMID 20722026